“I bring warm greetings from Sangrose….

The last 32 years for Sangrose has been an immensely gratifying experience. What that had started as a small unit in 1987, is now a significant player in the Indian Pharmaceutical Industry. We have evolved as an organization whose strengths are its People, Processes and Customer Focus. And we have established our leadership in the market by leveraging these strengths.

The Indian Pharmaceutical Industry is poised for exponential growth. Globalization has opened up new opportunities and India with its inherent strengths is set to be the biggest beneficiary.

Our Company’s ambitious plans for the future will be fuelled by a subsidiary named Sangrose Drug Chem Pvt. Ltd., which intends to manufacture Basic Drugs along with – spreading the roots of Specialty Marketing Division across the Country, New product Launches, Entry of Products in Global Regulated Markets and Contract Manufacturing.

The Company has set up modern manufacturing facilities conforming to International Standards. This provides us exclusive production facilities for oral liquids, tablets, capsules and topicals, apart from giving us the additional capacity to undertake contract manufacturing. These units are specifically built to international specifications and is able to handle export orders from the US and Europe in addition to our existing markets in Asia and Africa.

The Research & Development division has been established so as to attract partnerships from International Pharmaceutical Companies for contract research apart from addressing the in-house research initiatives.

Leveraging our innate strength along with the new initiatives, I am sure we will enable Sangrose Laboratories to emerge as a global leader in the foreseeable future.”